PT  - JOURNAL ARTICLE
AU  - Maria Miklowski
AU  - Bruce Jansen
AU  - Moises Auron
AU  - Christopher Whinney
TI  - The hospitalized patient with COVID-19 on the medical ward: Cleveland Clinic approach to management
AID  - 10.3949/ccjm.87a.ccc064
DP  - 2020 Nov 03
TA  - Cleveland Clinic Journal of Medicine
4099  - http://www.ccjm.org/content/early/2020/10/29/ccjm.87a.ccc064.short
4100  - http://www.ccjm.org/content/early/2020/10/29/ccjm.87a.ccc064.full
AB  - SARS-CoV-2-infected inpatients who are admitted to a noncritical care medical ward require a standardized approach that is based on evidence if available, and effective supportive and respiratory care. Outcomes are better when patients receive standardized care, in special COVID-19 wards in the hospital, from clinical teams with expertise. Available evidence and guidelines should be continuously appraised and integrated into clinical protocols for all domains of treatment, including isolation, and personal protective measures, pharmacologic therapy, and transitions of care. Inpatient pharmacologic therapy at this time consists primarily of dexamethasone and remdesivir, along with thromboprophylaxis, given the coagulopathy associated with COVID-19. This article summarizes current practices in our organization.